Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HELP Trial: LOLA and PEG in Overt Hepatic Encephalopathy
NCT05920213Phase 4Unknown
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Oct 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of l-ornithine l-aspartate, polyethylene glycol 3350 + bisacodyl in hepatic encephalopathy (HE), sponsored by Jinnah Postgraduate Medical Centre. Status: unknown.
02
Drugs
l-ornithine l-aspartatepolyethylene glycol 3350 + bisacodyl
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT05920213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05920213.